Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK536690PMID: 30694622
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 864821-90-9
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of eluxadoline during breastfeeding. Because it has opioid agonist activity, an alternate drug is preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Irritable Bowel syndrome) Alosetron, Cholestyramine, Colesevelam, Colestipol, Loperamide, Ondansetron, Rifaximin
Substance Identification
Substance Name
Eluxadoline
CAS Registry Number
864821-90-9
Drug Class
- Breastfeeding
- Gastrointestinal Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.[Fed Regist. 2015]Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.Drug Enforcement Administration, Department of Justice. Fed Regist. 2015 Nov 12; 80(218):69861-4.
- Review Canagliflozin.[Drugs and Lactation Database (...]Review Canagliflozin.. Drugs and Lactation Database (LactMed®). 2006
- Review Valsartan.[Drugs and Lactation Database (...]Review Valsartan.. Drugs and Lactation Database (LactMed®). 2006
- Review Peramivir.[Drugs and Lactation Database (...]Review Peramivir.. Drugs and Lactation Database (LactMed®). 2006
- Review Telithromycin.[Drugs and Lactation Database (...]Review Telithromycin.. Drugs and Lactation Database (LactMed®). 2006
- Eluxadoline - Drugs and Lactation Database (LactMed®)Eluxadoline - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...